Skip to content

Endoscopic Suturing System for Tissue Apposition

Evaluation of an Endoscopic Suturing System for Tissue Apposition

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00495222
Enrollment
9
Registered
2007-07-03
Start date
2007-02-28
Completion date
2008-06-30
Last updated
2009-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

gastrojejunostomy, stoma

Brief summary

The objective of this feasibility trial is to evaluate the Ethicon Endo-Surgery Endoscopic Suturing System (ESS) for tissue apposition and reduction of the size of a dilated GJ anastomosis in subjects who are regaining weight after successful weight loss following gastric bypass. Post-procedure weight will be followed to assess whether weight loss is resumed. The ESS is an FDA-cleared (510(k)) sterile, single-use, disposable suturing system indicated for endoscopic placement of suture(s) and approximation of soft tissues. It is designed to facilitate endoscopic gastrointestinal procedures.

Interventions

PROCEDURETissue plication

Tissue apposition and plication of a dilated GJ anastomosis with the Endoscopic Suturing System

DEVICEEndoscopic Suturing System

Tissue plication of dilated GJ stoma

DEVICETissue Plication

Tissue plication for GJ stoma reduction

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Subjects must fulfill the following criteria to be entered in this study: * Review and sign informed consent; * Between 21 and 65 years of age (inclusive) at time of trial enrollment; * Documented Roux-en-Y Gastric Bypass (RYGB) surgery date * Documented baseline weight at the time of RYGB procedure; * \> 12 months post RYGB); * Body mass Index (BMI) \> 30 and at least 20 pounds in excess of post-RYGB weight nadir; * Patients initially achieved at least 50% excess weight loss (EWL) post RYGB; * Visible anastomotic junction (between gastric pouch and the Roux-limb); * Stoma size at screening \> 15mm; and * Negative serum pregnancy test for women of childbearing potential.

Exclusion criteria

Subjects will be excluded from the trial for any of the following: * Documented history of esophageal pathology (e.g., esophageal varices, Barrett's Esophagus); * American Anesthesia Association (ASA) Class IV or V and/or any contraindications to monitored anesthesia; * Documented history of GJ anastomosis stricture (within 6 months); * Documented history of previous RYGB revision; * Presence or documented presence of gastric/duodenal ulcers; * Presence of sepsis; * Medical or physical endoscopic contraindications, including esophageal varices or bleeding, laryngeal perforation, trauma to pharynx, aspiration pneumonia, acute peritonitis, and other conditions where general endoscopic techniques and/or placement of overtube are contraindicated; * Chronic Non-Steroidal Anti-Inflammatory Drug (NSAID) use (subjects taking a single aspirin tablet per day for cardioprotection are considered acceptable); * Uncontrolled diabetes; * Physical or psychological condition which would impair trial participation per investigator discretion; * Binge-eating or similar eating disorders; * Unable or unwilling to attend follow-up visits and examinations; * Concurrent surgical procedure (intra-operative exclusion during ESS procedure); * Participation in any other investigational device or drug trial within 30 days prior to enrollment; or * Any condition, which precludes compliance with the trial.

Design outcomes

Primary

MeasureTime frameDescription
Knotting Elements Placedintra-operativecompletion of plication (1-3 knotting elements placed per procedure)

Countries

United States

Participant flow

Participants by arm

ArmCount
Tissue Plication9
Total9

Baseline characteristics

CharacteristicTissue Plication
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
Age Continuous35.5 years
STANDARD_DEVIATION 5.5
Region of Enrollment
United States
9 participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
2 Participants

Outcome results

Primary

Knotting Elements Placed

completion of plication (1-3 knotting elements placed per procedure)

Time frame: intra-operative

Population: Intent to Treat

ArmMeasureValue (NUMBER)
Tissue PlicationKnotting Elements Placed11 elements

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026